Pancreatic Neuroendocrine Carcinoma
Also known as: Neuroendocrine Carcinomas of Pancreas / Neuroendocrine Carcinoma of Pancreas / Neuroendocrine carcinoma of pancreas (disorder)
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB14554 | Dotatate | 0 | Withdrawn | 1 |
DB08885 | Aflibercept | 2 | Completed | 1 |
DB01101 | Capecitabine | 2 | Active Not Recruiting | 1 |
DB00958 | Carboplatin | 2 | Active Not Recruiting | 1 |
DB00515 | Cisplatin | 2 | Active Not Recruiting | 1 |
DB18155 | ESK981 | 2 | Not Yet Recruiting | 1 |
DB00773 | Etoposide | 2 | Active Not Recruiting | 1 |
DB00099 | Filgrastim | 2 | Terminated | 1 |
DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB01268 | Sunitinib | 2 | Recruiting | 1 |
DB00853 | Temozolomide | 2 | Active Not Recruiting | 1 |
DB09156 | Iopromide | Not Available | Unknown Status | 1 |